<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33620270</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2167-9223</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5-6</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Amyotrophic lateral sclerosis &amp; frontotemporal degeneration</Title><ISOAbbreviation>Amyotroph Lateral Scler Frontotemporal Degener</ISOAbbreviation></Journal><ArticleTitle>Progressive arm muscle weakness in ALS follows the same sequence regardless of onset site: use of TOMS, a novel analytic method to track limb strength.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>387</EndPage><MedlinePgn>380-387</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21678421.2021.1889000</ELocationID><Abstract><AbstractText><i>Objective</i>: Examine sequence of weakness in arm muscles from longitudinal hand-held dynamometry (HHD) data in ALS for congruence with contiguous spread of neurodegeneration along spinal cord segments. <i>Methods</i>: Longitudinal HHD data from the Ceftriaxone clinical trial were examined using nonlinear mixed models, assuming a logistic trajectory from normal to zero strength. Unobserved baseline normal strength of weak muscles was assumed using strength of the best-preserved muscle. A novel metric called "time from onset to midway strength" (TOMS) was estimated for each muscle group, and TOMS ratios were examined to identify sequence of weakness, overall and by onset site. <i>Results</i>: Shoulder flexion (SF), elbow flexion (EF), elbow extension (EE), wrist extension (WE), and first dorsal interosseous (FDI) were measured on each side. Over a median of 36 weeks, 513 subjects provided 2589 sets of HHD measures. TOMS increased sequentially in the following order: FDI, WE, SF, EF, and EE. TOMS ratios estimates with 95% CIs (adjusted for multiple comparisons) were: WE/FDI 1.32 (1.24-1.41), SF/WE 1.06 (1.01-1.10), EF/SF 1.06 (1.02-1.10), and EE/EF 1.18 (1.12-1.23). Elbow and shoulder flexors weakened sooner than did elbow extensors. The sequence of arm muscle weakness progression was similar regardless of onset site. <i>Conclusion</i>: Nonsegmental progression of arm muscle weakness that is similar for different onset sites favors cortical influence/network spread over contiguous spread of neurodegeneration in the spinal cord. Furthermore, this study confirms the "split elbow" pattern. TOMS and other proposed methods may have value as outcome measures in clinical research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thakore</LastName><ForeName>Nimish J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0003-3418-3362</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Center, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Drawert</LastName><ForeName>Brian J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Department of Computer Science, University of North Carolina at Asheville, Asheville, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lapin</LastName><ForeName>Brittany R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Quantitative Health Sciences/Neurological Institute Center for Outcomes Research and Evaluation (NICORE), Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pioro</LastName><ForeName>Erik P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Department of Neurology, Neuromuscular Center, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Lerner Research Institute, Cleveland Clinic, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB014877</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Amyotroph Lateral Scler Frontotemporal Degener</MedlineTA><NlmUniqueID>101587185</NlmUniqueID><ISSNLinking>2167-8421</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001132" MajorTopicYN="N">Arm</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018908" MajorTopicYN="Y">Muscle Weakness</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016059" MajorTopicYN="N">Range of Motion, Articular</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Muscle strength</Keyword><Keyword MajorTopicYN="N">dissociated muscle atrophy</Keyword><Keyword MajorTopicYN="N">hand-held dynamometry</Keyword><Keyword MajorTopicYN="N">non-linear mixed models</Keyword></KeywordList><CoiStatement>Declaration of interest. No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33620270</ArticleId><ArticleId IdType="mid">NIHMS1703924</ArticleId><ArticleId IdType="pmc">PMC8292176</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1889000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S Split elbow sign: more evidence for the importance of cortical dysfunction in ALS. J Neurol Neurosurg Psychiatry. 2019;90:729.</Citation><ArticleIdList><ArticleId IdType="pubmed">30910859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Emilian S, Dreyhaupt J, Rosenbohm A, Kraskov A, Lemon RN, et al. Pattern of paresis in ALS is consistent with the physiology of the corticomotoneuronal projections to different muscle groups. J Neurol Neurosurg Psychiatry. 2020;91:991&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32665323</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MS, Woodhouse H, McCombe PA, Henderson RD. The relationship between limb dominance, disease lateralization and spread of weakness in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:150&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">22985430</ArticleId></ArticleIdList></Reference><Reference><Citation>Shayya L, Babu S, Pioro EP, Li J, Li Y. Distal predominance of electrodiagnostic abnormalities in early-stage amyotrophic lateral sclerosis. Muscle Nerve. 2018;58:389&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742797</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen S, Ballantyne JP. A quantitative electrophysiological study of motor neurone disease. J Neurol Neurosurg Psychiatry. 1978;41:773&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC493153</ArticleId><ArticleId IdType="pubmed">690647</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbourn AJ. The &#x201c;split hand syndrome&#x201d;. Muscle Nerve. 2000;23:138.</Citation><ArticleIdList><ArticleId IdType="pubmed">10590421</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon NG, Lee M, Bae JS, Mioshi E, Lin CS-Y, Pfluger CM, et al. Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis. J Neurol. 2015;262:1424&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">25845764</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalaf R, Martin S, Ellis C, Burman R, Sreedharan J, Shaw C, et al. Relative preservation of triceps over biceps strength in upper limb-onset ALS: the &#x201c;split elbow&#x201d;. J Neurol Neurosurg Psychiatry. 2019;90:730&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6585260</ArticleId><ArticleId IdType="pubmed">30846542</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM. Strength testing in motor neuron diseases. Neurotherapeutics. 2017;14:154&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5233619</ArticleId><ArticleId IdType="pubmed">27600518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW. Considerations and practical options for measuring muscle strength: a narrative review. Biomed Res Int. 2019;2019:8194537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6354207</ArticleId><ArticleId IdType="pubmed">30792998</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Liu D, Leitner ML, Schoenfeld D, Johns DR, Ferguson T, et al. Quantitative strength testing in ALS clinical trials. Neurology. 2016;87:617&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4977369</ArticleId><ArticleId IdType="pubmed">27385750</ArticleId></ArticleIdList></Reference><Reference><Citation>Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:1083&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4216315</ArticleId><ArticleId IdType="pubmed">25297012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW, Magasi SR, Bubela DJ, Wang Y-C, Gershon RC. Grip and knee extension muscle strength reflect a common construct among adults. Muscle Nerve. 2012;46:555&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448119</ArticleId><ArticleId IdType="pubmed">22987697</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushton DJ, Andres PL, Allred P, Baloh RH, Svendsen CN. Patients with ALS show highly correlated progression rates in left and right limb muscles. Neurology. 2017;89:196&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501935</ArticleId><ArticleId IdType="pubmed">28600459</ArticleId></ArticleIdList></Reference><Reference><Citation>Seber GA, Lee AJ. Linear regression analysis. 2nd ed. Hoboken, NJ: John Wiley &amp; Sons, Inc.; 2003.</Citation></Reference><Reference><Citation>Pinheiro J, Bates D, DebRoy S, Sarkar D. R Core Team. nlme: linear and nonlinear mixed effects models [Internet]; 2020. Available at: https://CRAN.R-project.org/package=nlme.</Citation></Reference><Reference><Citation>Eisen A, Kim S, Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron? Muscle Nerve. 1992;15:219&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Braak H, Del Tredici K, Lemon R, Ludolph AC, Kiernan MC. Cortical influences drive amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88:917&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Wicks P, Brownstein CA, Massagli MP, Toronjo M, Talbot K, et al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatr. 2011;82:853&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20562391</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro E, Thakore N. Handedness and side of onset in limb-onset ALS: is there a connection? Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:86&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Verstraete E, van den Heuvel MP, Veldink JH, van den Berg LH. Patterns of symptom development in patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:21&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29037065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW. Measuring knee extensor muscle strength. Am J Phys Med Rehabil. 2001;80:13&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11138949</ArticleId></ArticleIdList></Reference><Reference><Citation>Bromberg MB, Forshew DA, Nau KL, Bromberg J, Simmons Z, Fries TJ. Motor unit number estimation, isometric strength, and electromyographic measures in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1213&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8413373</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns D, Liu D, Ferguson T, Cedarbaum JM. Methods for evaluating patients (application number 15/629,424, publication number 20180064386) [Internet]; 2018. Available at: www.uspto.gov.
Accessed August 31, 2020.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>